Corrigendum to ‘‘A highly selective fluorescent ESIPT probe for the detection of human carboxylesterase 2 and its biological applications” (Biosens. Bioelectron. (2015) 65 (9–15), (S0956-5663(14)00786-6), (10.1016/j.bios.2014.10.002));A highly selective fluorescent ESIPT probe for the detection of human carboxylesterase 2 and its biological applications

Biosensors and Bioelectronics

Volumn 65, Issue , 2015, Pages 9-15

  Feng, Lei ^a,b   Liu, Zhao Ming ^b   Hou, Jie ^c   Lv, Xia ^b   Ning, Jing ^b,c   Ge, Guang Bo ^a,b   Cui, Jing Nan ^a   Yang, Ling ^b  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

3 Hydroxylflavone; Bioimaging; Human carboxylesterase 2; Ratiometric fluorescent probe

Indexed keywords

CYTOLOGY; ENZYMES; EXCITED STATES; FLUORESCENCE;

3-HYDROXYLFLAVONE; BIO-IMAGING; BIOLOGICAL APPLICATIONS; CARBOXYLESTERASES; EXCITED-STATE INTRAMOLECULAR PROTON TRANSFER; FLUORESCENT PROBES; INDIVIDUAL DIFFERENCES; PHYSIOLOGICAL CONDITION;

PROBES;

3 HYDROXYFLAVONE; 4 ETHYLBENZOYLOXY; ARYLDIALKYLPHOSPHATASE; BENZOIC ACID DERIVATIVE; CARBOXYLESTERASE; CARBOXYLESTERASE 1; CARBOXYLESTERASE 2; CHOLINESTERASE; FLUORESCENT DYE; RATIOMETRIC FLUORESCENT PROBE; UNCLASSIFIED DRUG; 3-HYDROXYFLAVONE; CES2 PROTEIN, HUMAN; ENZYME INHIBITOR; FLAVONOID;

ARTICLE; ASSAY; CELL MEMBRANE PERMEABILITY; CHEMICAL INHIBITION ASSAY; CHEMICAL REACTION; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; HUMAN TISSUE; HYDROLYSIS; INTRAMOLECULAR PROTON TRANSFER EMISSION; PROTON TRANSPORT; ANTAGONISTS AND INHIBITORS; CHEMISTRY; ENZYME ASSAY; FLUORESCENCE IMAGING; GENETIC PROCEDURES; HELA CELL LINE; PRECLINICAL STUDY; PROCEDURES; SPECTROFLUOROMETRY;

BIOSENSING TECHNIQUES; CARBOXYLESTERASE; DRUG EVALUATION, PRECLINICAL; ENZYME ASSAYS; ENZYME INHIBITORS; FLAVONOIDS; FLUORESCENT DYES; HELA CELLS; HUMANS; OPTICAL IMAGING; SPECTROMETRY, FLUORESCENCE;

EID: 84907990249     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2019.111559     Document Type: Erratum

References (30)

1. Chen Y., Zhu C., Yang Z., Chen J., He Y., Jiao Y., He W., Qiu L., Cen J., Guo Z. A ratiometric fluorescent probe for rapid detection of hydrogen sulfide in mitochondria. Angew. Chem. Int. Ed. Engl. 2013, 52(6):1688-1691.
2. Cui L., Zhong Y., Zhu W., Xu Y., Qian X. Selective and sensitive detection and quantification of arylamine N-acetyltransferase 2 by a ratiometric fluorescence probe. Chem. Commun. (Camb.) 2010, 46(38):7121-7123.
3. Danks M.K., Morton C.L., Krull E.J., Cheshire P.J., Richmond L.B., Naeve C.W., Pawlik C.A., Houghton P.J., Potter P.M. Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy. Clin. Cancer. Res. 1999, 5(4):917-924.
4. Fernandez-Suarez M., Ting A.Y. Fluorescent probes for super-resolution imaging in living cells. Nat. Rev. Mol. Cell Biol. 2008, 9(12):929-943.
5. Gross E., Bedlack R.S., Loew L.M. Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential. Biophys. J. 1994, 67(1):208-216.
6. Ha T., Tinnefeld P. Photophysics of fluorescent probes for single-molecule biophysics and super-resolution imaging. Annu. Rev. Phys. Chem. 2012, 63:595-617.
7. Hakamata W., Machida A., Oku T., Nishio T. Design and synthesis of an ER-specific fluorescent probe based on carboxylesterase activity with quinone methide cleavage process. Bioorg. Med. Chem. Lett. 2011, 21(11):3206-3209.
8. Hatfield J.M., Wierdl M., Wadkins R.M., Potter P.M. Modifications of human carboxylesterase for improved prodrug activation. Expert Opin. Drug Metab. Toxicol 2008, 4(9):1153-1165.
9. Hosokawa M. Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs. Molecules (Basel, Switzerland) 2008, 13:412-431.
10. Hyatt J.L., Tsurkan L., Wierdl M., Edwards C.C., Danks M.K., Potter P.M. Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicity. Mol. Cancer Ther. 2006, 5(9):2281-2288.
11. Imai T. Human carboxylesterase isozymes: catalytic properties and rational drug design. Drug Metab. Pharmacokinet. 2006, 21(3):173-185.
12. Kim Y., Choi Y., Weissleder R., Tung C.H. Membrane permeable esterase-activated fluorescent imaging probe. Bioorg. Med. Chem. Lett. 2007, 17(18):5054-5057.
13. Liu Z.M., Feng L., Ge G.B., Lv X., Hou J., Cao Y.F., Cui J.N., Yang L. A highly selective ratiometric fluorescent probe for in vitro monitoring and cellular imaging of human carboxylesterase 1. . Biosens. Bioelectron. 2014, 57c:30-35.
14. Ma M.K., McLeod H.L. Lessons learned from the irinotecan metabolic pathway. Curr. Med. Chem. 2003, 10(1):41-49.
15. Pratt S.E., Durland-Busbice S., Shepard R.L., Heinz-Taheny K., Iversen P.W., Dantzig A.H. Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cells. Clin. Cancer Res. 2013, 19(5):1159-1168.
16. Redinbo M.R., Bencharit S., Potter P.M. Human carboxylesterase 1: from drug metabolism to drug discovery. Biochem. Soc. Trans. 2003, 31(Pt 3):620-624.
17. Redinbo M.R., Potter P.M. Mammalian carboxylesterases: from drug targets to protein therapeutics. Drug Discov. Today 2005, 10(5):313-325.
18. Sanghani S.P., Quinney S.K., Fredenburg T.B., Davis W.I., Murry D.J., Bosron W.F. Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3. Drug Metab. Dispos. 2004, 32(5):505-511.
19. Sanghani S.P., Quinney S.K., Fredenburg T.B., Sun Z., Davis W.I., Murry D.J., Cummings O.W., Seitz D.E., Bosron W.F. Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis. Clin. Cancer Res. 2003, 9(13):4983-4991.
20. Satoh T., Hosokawa M. The mammalian carboxylesterases: from molecules to functions. Annu. Rev. Pharmacol. Toxicol. 1998, 38:257-288.
21. Schiel M.A., Green S.L., Davis W.I., Sanghani P.C., Bosron W.F., Sanghani S.P. Expression and characterization of a human carboxylesterase 2 splice variant. J. Pharmacol. Exp. Ther. 2007, 323(1):94-101.
22. Shi D., Yang J., Yang D., LeCluyse E.L., Black C., You L., Akhlaghi F., Yan B. Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel. J. Pharmacol. Exp. Ther. 2006, 319(3):1477-1484.
23. Wadkins R.M., Hyatt J.L., Yoon K.J., Morton C.L., Lee R.E., Damodaran K., Beroza P., Danks M.K., Potter P.M. Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity. Mol. Pharmacol. 2004, 65(6):1336-1343.
24. Wang J., Williams E.T., Bourgea J., Wong Y.N., Patten C.J. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2. Drug Metab. Dispos. 2011, 39(8):1329-1333.
25. Wang X., Sun J., Zhang W., Ma X., Lv J., Tang B. A near-infrared ratiometric fluorescent probe for rapid and highly sensitive imaging of endogenous hydrogen sulfide in living cells. . Chem. Sci. 2013, 4(6):2551-2556.
26. Wheelock C.E., Phillips B.M., Anderson B.S., Miller J.L., Miller M.J., Hammock B.D. Applications of carboxylesterase activity in environmental monitoring and toxicity identification evaluations (TIEs). Rev. Environ. Contam. Toxicol. 2008, 195:117-178.
27. Xie M., Yang D., Liu L., Xue B., Yan B. Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression. Drug Metab. Dispos. 2002, 30(5):541-547.
28. Xu G., Zhang W., Ma M.K., McLeod H.L. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan. Clin. Cancer Res. 2002, 8(8):2605-2611.
29. Zhang J., Campbell R.E., Ting A.Y., Tsien R.Y. Creating new fluorescent probes for cell biology. Nat. Rev. Mol. Cell Biol. 2002, 3(12):906-918.
30. Zhang Y., Chen W., Feng D., Shi W., Li X., Ma H. A spectroscopic off-on probe for simple and sensitive detection of carboxylesterase activity and its application to cell imaging. Analyst 2012, 137(3):716-721.